Charlotte Meredith Freeland

Charlotte Meredith Freeland

Auto-generated profile, based on publicly available information

Charlotte Meredith Freeland

Department of Psychiatry, Connecticut Mental Health Center, Yale School of Medicine, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ENEric J. Nunes
Eric J. Nunes
PRPatrick A. Randall
Patrick A. Randall
EHEvan E. Hart
Evan E. Hart
CFCharlotte Freeland
Charlotte Freeland
SYSamantha E. Yohn
Samantha E. Yohn
JSJohn D. Salamone
John D. Salamone
Motivated behaviors are often characterized by a high degree of behavioral activation, and work output and organisms frequently make effort-related decisions based upon cost/benefit analyses. Moreover, people with major depression and other disorders often show effort-related motivational symptoms such as anergia, psychomotor retardation, and fatigue. It has been suggested that tasks measuring effort-related choice behavior could be used as animal models of the motivational symptoms of depression, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT) inhibitor tetrabenazine. Tetrabenazine produces depressive symptoms in humans and, because of its selective inhibition of VMAT-2, it preferentially depletes dopamine (DA). Rats were assessed using a concurrent fixed-ratio 5/chow feeding choice task that is known to be sensitive to dopaminergic manipulations. Tetrabenazine shifted response choice in rats, producing a dose-related decrease in lever pressing and a concomitant increase in chow intake. However, it did not alter food intake or preference in parallel free-feeding choice studies. The effects of tetrabenazine on effort-related choice were reversed by the adenosine A2Aantagonist MSX-3 and the antidepressant bupropion. A behaviorally active dose of tetrabenazine decreased extracellular DA in nucleus accumbens and increased expression of DARPP-32 in accumbens medium spiny neurons in a pattern indicative of reduced transmission at both D1and D2DA receptors. These experiments demonstrate that tetrabenazine, which is used in animal models to produce depression-like effects, can alter effort-related choice behavior. These studies have implications for the development of animal models of the motivational symptoms of depression and related disorders.

23 May 2018 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
RTRebecca L. Tom
Rebecca L. Tom
AAAarit Ahuja
Aarit Ahuja
HMHannah Maniates
Hannah Maniates
CFCharlotte M. Freeland
Charlotte M. Freeland
MRMike J. F. Robinson
Mike J. F. Robinson

1 October 2019 in Behavioural Brain Research
Verified
Journal Article
Closed access
MRMike J.F. Robinson
Mike J.F. Robinson
CCCallie Clibanoff
Callie Clibanoff
CFCharlotte M. Freeland
Charlotte M. Freeland
AKAnna S. Knes
Anna S. Knes
JCJohn R. Cote
John R. Cote
TRTrinity I. Russell
Trinity I. Russell

30 April 2020 in Current Opinion in Behavioral Sciences
Verified
Journal Article
Closed access
CFCharlotte Meredith Freeland
Charlotte Meredith Freeland
AKAnna Shen Knes
Anna Shen Knes
MRMike James Ferrar Robinson
Mike James Ferrar Robinson

1 March 2020 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
MRMike J.F. Robinson
Mike J.F. Robinson
KCKian A. Caplan
Kian A. Caplan
AKAnna S. Knes
Anna S. Knes
HRHely O. Rodríguez-Cruz
Hely O. Rodríguez-Cruz
CCCallie Clibanoff
Callie Clibanoff
CFCharlotte M. Freeland
Charlotte M. Freeland